One would hope that increases in the number of centers that are enrolling patients and word of mouth amongst practitioners around the effectiveness of MSCs in ARDS would see a continuing uptick in the speed of enrollment, so maybe the remaining 50% can be done faster than the initial 50%.
Anyway, the fact that we are now past the 45%, and likely quite near the 60%, means for certain that SI's comments about an "early November" review by the DSMB is spot on and an announcement thereabouts is a lock.
- Forums
- ASX - By Stock
- Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
MSB
mesoblast limited
Add to My Watchlist
4.15%
!
$2.31

One would hope that increases in the number of centers that are...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $2.956B |
Open | High | Low | Value | Volume |
$2.33 | $2.35 | $2.15 | $30.94M | 13.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 10350 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | 2.300 |
1 | 8580 | 2.290 |
2 | 10438 | 2.280 |
7 | 19928 | 2.270 |
3 | 9726 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 10350 | 2 |
2.340 | 56503 | 6 |
2.350 | 108804 | 14 |
2.360 | 31450 | 3 |
2.380 | 18175 | 4 |
Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |